213 related articles for article (PubMed ID: 16970254)
1. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
[TBL] [Abstract][Full Text] [Related]
2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
4. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
7. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
[TBL] [Abstract][Full Text] [Related]
9. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis.
Nasri H; Baradaran A
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):215-9. PubMed ID: 17496397
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
[TBL] [Abstract][Full Text] [Related]
11. On-line haemodiafiltration improves response to calcifediol treatment.
Pérez-García R; Albalate M; de Sequera P; Alcázar R; Puerta M; Ortega M; Corchete E
Nefrologia; 2012 Jul; 32(4):459-66. PubMed ID: 22652556
[TBL] [Abstract][Full Text] [Related]
12. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
[TBL] [Abstract][Full Text] [Related]
15. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
16. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
Bradran A; Nasri H
J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
McGonigle RJ; Weston MJ; Keenan J; Jackson DB; Parsons V
Magnesium; 1984; 3(1):1-7. PubMed ID: 6482508
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum parathyroid hormone levels and lipid profile in non-diabetic hemodialysis patients.
Ahmadi F; Mirjafari SR; Khatami Mr; Khazaeipour Z; Ranjbarnovin N
Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1188-95. PubMed ID: 23168847
[TBL] [Abstract][Full Text] [Related]
20. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
